(Press-News.org) (SACRAMENTO, Calif.) — Researchers with the UC Davis MIND Institute and Agilent Laboratories have found that Prader-Willi syndrome — a genetic disorder best known for causing an insatiable appetite that can lead to morbid obesity — is associated with the loss of non-coding RNAs, resulting in the dysregulation of circadian and metabolic genes, accelerated energy expenditure and metabolic differences during sleep.
The research was led by Janine LaSalle, a professor in the UC Davis Department of Medical Microbiology and Immunology who is affiliated with the MIND Institute. It is published online in Human Molecular Genetics.
"Prader-Willi syndrome children do not sleep as well at night and have daytime sleepiness," LaSalle said. "Parents have to lock up their pantries because the kids are rummaging for food in the middle of the night, even breaking into their neighbors' houses to eat."
The study found that these behaviors are rooted in the loss of a long non-coding RNA that functions to balance energy expenditure in the brain during sleep. The finding could have a profound effect on how clinicians treat children with Prader-Willi, as well as point the way to new, innovative therapies, LaSalle said.
The leading cause of morbid obesity among children in the United States, Prader-Willi involves a complex, and sometimes contradictory, array of symptoms. Shortly after birth children with Prader-Willi experience failure to thrive. Yet after they begin to feed themselves, they have difficulty sleeping and insatiable appetites that lead to obesity if their diets are not carefully monitored.
The current study was conducted in a mouse model of Prader-Willi syndrome. It found that mice engineered with the loss of a long non-coding RNA showed altered energy use and metabolic differences during sleep.
Prader-Willi has been traced to a specific region on chromosome 15 (SNORD116), which produces RNAs that regulate gene expression, rather than coding for proteins. When functioning normally, SNORD116 produces small nucleolar (sno) RNAs and a long non-coding RNA (116HG), as well as a third non-coding RNA implicated in a related disorder, Angelman syndrome. The 116HG long non-coding RNA forms a cloud inside neuronal nuclei that associates with proteins and genes regulating diurnal metabolism in the brain, LaSalle said.
"We thought the cloud would be activating transcription, but in fact it was doing the opposite," she said. "Most of the genes were dampened by the cloud. This long non-coding RNA was acting as a decoy, pulling the active transcription factors away from genes and keeping them from being expressed."
As a result, losing snoRNAs and 116HG causes a chain reaction, eliminating the RNA cloud and allowing circadian and metabolic genes to get turned on during sleep periods, when they should be dampened down. This underlies a complex cycle in which the RNA cloud grew during sleep periods (daytime for nocturnal mice), turning down genes associated with energy use, and receded during waking periods, allowing these genes to be expressed. Mice without the 116HG gene lacked the benefit of this neuronal cloud, causing greater energy expenditure during sleep.
The researchers said that the work provides a clearer picture of why children with Prader-Willi syndrome can't sleep or feel satiated and may change therapeutic approaches. For example, many such children have been treated with growth hormone because of short stature, but this actually may boost other aspects of the disease.
"People had thought the kids weren't sleeping at night because of the sleep apnea caused by obesity," said LaSalle. "What this study shows is that the diurnal metabolism is central to the disorder, and that the obesity may be as a result of that. If you can work with that, you could improve therapies, for example figuring out the best times to administer medications."
###
The study's other study authors include Weston T. Powell, Rochelle L. Coulson, Florence K. Crary, Spencer S. Wong, Robert A. Ach and Dag H. Yasui, all of UC Davis, and Peter Tsang and N. Alice Yamada of Agilent Laboratories.
The work was funded by National Institutes of Health grants F31NS073164 and 1R01NS076263 and the Prader-Willi Foundation.
At the UC Davis MIND Institute, world-renowned scientists engage in collaborative, interdisciplinary research to find the causes of and develop treatments and cures for autism, attention-deficit/hyperactivity disorder (ADHD), fragile X syndrome, 22q11.2 deletion syndrome, Down syndrome and other neurodevelopmental disorders. For more information, visit http://mindinstitute.ucdavis.edu.
Symptoms of Prader-Willi syndrome associated with interference in circadian, metabolic genes
2013-06-26
ELSE PRESS RELEASES FROM THIS DATE:
Laser guided codes advance single pixel terahertz imaging
2013-06-26
VIDEO:
A new method for single pixel terahertz (THz) imaging developed by Boston College researchers uses a set of instructions delivered by a laser beam to tune THz waves in order...
Click here for more information.
CHESTNUT HILL, MA (June 25, 2013) – The universe is awash in terahertz (THz) waves, as harmless as they are abundant. But unlike other regions of the electromagnetic spectrum, THz has proven to be extremely difficult to manipulate in order to capture novel images ...
Blind(fold)ed by science: Study shows the strategy humans use to chase objects
2013-06-26
COLUMBUS, Ohio—A new study has found that chasing down a moving object is not only a matter of sight or of sound, but of mind.
The study found that people who are blindfolded employ the same strategy to intercept a running ball carrier as people who can see, which suggests that multiple areas of the brain cooperate to accomplish the task.
Regardless of whether they could see or not, the study participants seemed to aim ahead of the ball carrier's trajectory and then run to the spot where they expected him or her to be in the near future. Researchers call this a "constant ...
Immunohistochemistry effectively detects ALK rearrangement
2013-06-26
DENVER – ALK rearrangement has been demonstrated to be a potent oncogenic driver and a promising therapeutic target in non-small cell lung cancer (NSCLC). It defines a distinct molecular subset of NSCLC, in particular adenocarcinoma that can benefit by the treatment of ALK-inhibitors. Development of robust and reliable laboratory tests for predictive biomarkers is essential to select appropriate patients for targeted therapy.
Researchers from the Chinese University of Hong King evaluated the practical usefulness of immunohistochemistry to detect ALK expression as a reliable ...
Continued research needed on treatment for women with lung cancer who are never smokers
2013-06-26
DENVER – The incidence of lung cancer in women affects an estimated 516,000 women worldwide, of which 100,000 are in the United States and 70,000 in Europe. Until now, lung cancers occurring in women have been treated similarly to lung cancers in men. However, numerous studies have highlighted different characteristics of lung cancer in women.
Researchers at the University of Toulouse III in France aim to compare clinical, pathological and biological characteristics of lung cancer in cohorts of women smokers and women never-smokers. They looked at a total of 140 women, ...
PET-CT improves care of limited-stage small-cell lung cancer patients
2013-06-26
DENVER – Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC). Approximately 39 percent of patients with SCLC are diagnosed with limited-stage disease, meaning the cancer is only present in one lung, but may have spread to lymph nodes or tissue between the lungs. These patients are often treated with chemotherapy and definitive radiation therapy. Staging information is essential because of the high propensity for metastatic disease in SCLC, and the identification of metastases can spare patients from the toxicity ...
Study details cancer-promoting mechanisms of overlooked components in secondhand smoke
2013-06-26
Tobacco smoke, diesel exhaust and oil combustion carry polycyclic aromatic hydrocarbons – PAHs that are known to cause cancer. But of these PAHs, the obviously dangerous high-molecular-weight PAHs like benzo[a]pyrene (BaP) have received the vast majority of research attention. Their low-molecular-weight cousins have been largely overlooked, in part because studies have shown that these compounds alone aren't very successful at mutating genes in cancer-causing ways.
A University of Colorado Cancer Center study published in the journal PLoS One explores two of these low-molecular-weight ...
Vietnam vets with PTSD more than twice as likely to have heart disease
2013-06-26
Male twin Vietnam veterans with post-traumatic stress disorder (PTSD) were more than twice as likely as those without PTSD to develop heart disease during a 13-year period, according to a study supported by the National Institutes of Health.
This is the first long-term study to measure the association between PTSD and heart disease using objective clinical diagnoses combined with cardiac imaging techniques.
"This study provides further evidence that PTSD may affect physical health," said Gary H. Gibbons, M.D., director of the NIH's National Heart, Lung, and Blood ...
'Active surveillance' may miss aggressive prostate cancers in black men
2013-06-26
A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches. Although prior studies have found it safe to delay treatment and monitor some presumably slow-growing or low-risk prostate cancers, such "active surveillance" (AS) does not appear to be a good idea for black men, the study concludes.
"This study offers the most conclusive evidence to date that broad application ...
Hiding in plain sight: New species of bird discovered in capital city
2013-06-26
A team of scientists with the Wildlife Conservation Society, BirdLife International, and other groups have discovered a new species of bird with distinct plumage and a loud call living not in some remote jungle, but in a capital city of 1.5 million people.
Called the Cambodian tailorbird (Orthotomus chaktomuk), the previously undescribed species was found in Cambodia's urbanized capitol Phnom Penh and several other locations just outside of the city including a construction site. It is one of only two bird species found solely in Cambodia. The other, the Cambodian laughingthrush, ...
USC research IDs potential treatment for deadly, HIV-related blood cancer
2013-06-26
LOS ANGELES — Researchers at the USC Norris Comprehensive Cancer Center have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV.
The USC team shows that a class of drugs called BET bromodomain inhibitors effectively targets primary effusion lymphoma (PEL), a type of cancer for which those drugs were not expected to be effective.
"It's a reversal of the paradigm," said Preet Chaudhary, MD, PhD, chief of the Nohl Division of Hematology and Blood Diseases at the Keck School of Medicine of USC and ...